SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-009054
Filing Date
2018-11-08
Accepted
2018-11-08 17:07:42
Documents
63
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q kala-20180930x10q.htm 10-Q 1794830
2 EX-10.1 kala-20180930ex1017be098.htm EX-10.1 102521
3 EX-31.1 kala-20180930ex31146b9e5.htm EX-31.1 21328
4 EX-31.2 kala-20180930ex312241960.htm EX-31.2 21321
5 EX-32.1 kala-20180930ex321380fb3.htm EX-32.1 9002
6 EX-32.2 kala-20180930ex3220fe542.htm EX-32.2 9413
  Complete submission text file 0001558370-18-009054.txt   6233500

Data Files

Seq Description Document Type Size
7 EX-101.INS kala-20180930.xml EX-101.INS 1220795
8 EX-101.SCH kala-20180930.xsd EX-101.SCH 39438
9 EX-101.CAL kala-20180930_cal.xml EX-101.CAL 38677
10 EX-101.DEF kala-20180930_def.xml EX-101.DEF 149105
11 EX-101.LAB kala-20180930_lab.xml EX-101.LAB 381165
12 EX-101.PRE kala-20180930_pre.xml EX-101.PRE 293381
Mailing Address 100 BEAVER STREET SUITE 201 WALTHAM MA 02453
Business Address 100 BEAVER STREET SUITE 201 WALTHAM MA 02453 781-996-5252
Kala Pharmaceuticals, Inc. (Filer) CIK: 0001479419 (see all company filings)

IRS No.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38150 | Film No.: 181170526
SIC: 2834 Pharmaceutical Preparations